Company / Goodwill
Gilead Sciences Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$8.3B
FY2025
5-year range
$8.1B / $8.3B
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#9 of 74
Health Care
What the data says
Gilead Sciences's goodwill of $8.3B is higher than 88% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
$8.3B in FY2025 with a 5-year CAGR of +0.5%. Top quartile in the Health Care sector.
Remained stable around $8.3B over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- -0.1%
- 5-Year CAGR
- +0.5%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 74This company $8.3B Sector average $4.0B
▼
+107.0% above sector average
Key checks
Key Insights
- 5-year CAGR of +0.5%, indicating consistent growth.
- In FY2025, goodwill increased 0.0% year-over-year.
- Ranks #9 out of 74 companies in the Health Care sector.
- Peak goodwill was recorded in FY2022.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.3B | +0.0% |
| FY2024 | $8.3B | +0.0% |
| FY2023 | $8.3B | -0.2% |
| FY2022 | $8.3B | +2.8% |
| FY2021 | $8.1B | +0.0% |
| FY2020 | $8.1B | +96.9% |
| FY2019 | $4.1B | +0.0% |
| FY2018 | $4.1B | -1.0% |
| FY2017 | $4.2B | +254.9% |
| FY2016 | $1.2B | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026